108605-62-5CC(O)=C(C#N)C(=O)Nc1ccc(C(F)(F)F)cc1UTNUDOFZCWSZMS-UHFFFAOYSA-NDanger
H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]
P203, P264, P270, P273, P280, P301+P316, P318, P321, P330, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 2 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
BeschreibungTeriflunomide (Aubagio®), also known as A77 1726, is an immunosupressant marketed by Sanofi for the teatment of multiple sclerosis (MS). Teriflunomide is the active metabolite of leflunomide, used for treatment of patients diagnosed with rheumatoid arthritis, and therefore simultaneously can be used as a treatment for rheumatoid arthritis.Teriflunomide acts as an inhibitor of the mitochondrial enzyme dihydrorotate dehydrogenase, inhibiting pyrimidine formation, and resulting in reduced B and T cell proliferation.
VerwendenThe active metabolite of Leflunomide, 2-Cyano-3-hydroxy-N-(4'-trifluoromethylphenyl)-crotone amide can be used as a potent disease-modifying antirheumatic drug used in the treatment of rheumatoid arthritis.
Keine Reaktionsaufzeichnungen unter den aktuellen Filterkriterien.
Wird geladen…
108605-62-5DTXSID301043028CHEMBL2062101